Methaq Hadi lafta | Biotechnology | Best Academic Researcher Award

Best Academic Researcher Award

Methaq Hadi Lafta
Iraqi Ministry of Education, Iraq
Methaq Hadi Lafta
Affiliation Iraqi Ministry of Education
Country Iraq
Scopus ID 57210173431
Documents 17
Citations 266
h-index 7
Subject Area Biotechnology
Event Applied Scientist Awards
ORCID 0000-0002-9978-6829

Methaq Hadi Lafta has contributed to the fields of biotechnology, molecular biology, immunology, bioinformatics, and environmental sciences through a combination of peer-reviewed publications, editorial responsibilities, and international research collaborations.[1] The Best Academic Researcher Award recognizes distinguished scholarly achievements, scientific productivity, and sustained contributions to interdisciplinary research and academic advancement. His academic profile reflects continued engagement in scientific publishing, reviewer activities, and biomedical research dissemination within regional and international scholarly communities.[2]

Abstract

Methaq Hadi Lafta is associated with multidisciplinary research activities involving biotechnology, molecular diagnostics, cancer biology, nanomaterials, genetics, and biomedical sciences. His scholarly record includes publications indexed in international databases and participation in editorial and reviewer roles across scientific journals. The research profile demonstrates an emphasis on translational biomedical research, computational biology applications, and healthcare-related scientific investigations.[3] The academic contributions and publication metrics support consideration for recognition within the framework of the Applied Scientist Awards.[4]

Keywords

Biotechnology, Molecular Biology, Immunology, Bioinformatics, Genetics, Cancer Research, Nanotechnology, Biomedical Sciences, Scientific Publishing, Academic Research

Introduction

Academic recognition awards are intended to acknowledge researchers whose work contributes to scientific advancement, interdisciplinary collaboration, and evidence-based innovation. In biotechnology and biomedical sciences, contemporary research increasingly integrates computational modeling, molecular analysis, and translational applications aimed at improving healthcare and scientific understanding.[3]

Research Profile

Methaq Hadi Lafta encompasses biotechnology, immunology, microbiology, molecular biology, environmental sciences, and bioinformatics. The profile includes publications addressing autoimmune diseases, cancer biology, nanomaterials, recurrent pregnancy loss, heavy metal toxicity, and computational drug design methodologies.[3]

Research Contributions

Methaq Hadi Lafta involve both experimental and theoretical scientific approaches. Several studies focus on biomedical applications of molecular and cellular biology, particularly within cancer pathways, immunological regulation, and extracellular vesicle technologies.[4]

  • Investigation of extracellular vesicles in autoimmune diseases and stem-cell-derived therapeutic systems.
  • Studies involving MXene-based nanomaterials for microbial toxin sensing and food safety applications.

Publications

Selected publications attributed to Methaq Hadi Lafta include peer-reviewed studies and interdisciplinary biomedical investigations indexed in scholarly databases.[1]

  1. The Developing Role of Extracellular Vesicles in Autoimmune Diseases: Special Attention to Mesenchymal Stem Cell-Derived Extracellular Vesicles.
  2. Designing Effective Multi-Target Drugs and Identifying Biomarkers in Recurrent Pregnancy Loss (RPL) Using In Vivo, In Vitro, and In Silico Approaches.

Research Impact

Methaq Hadi Lafta is reflected through publication metrics, citation counts, and interdisciplinary research visibility. According to indexed scholarly data, the profile includes 17 documents with 266 citations and an h-index of 7, indicating measurable scholarly engagement and citation activity within biomedical and biotechnology research areas.[1]

Award Suitability

Methaq Hadi Lafta demonstrates characteristics relevant to the Best Academic Researcher Award within the Applied Scientist Awards framework. The profile combines scientific publications, editorial contributions, interdisciplinary investigations, and participation in international academic networks.[4]

The researcher’s work in biotechnology and biomedical sciences aligns with contemporary scientific priorities involving translational medicine, molecular diagnostics, and innovative therapeutic approaches. Citation metrics, publication activity, and peer-review involvement collectively support suitability for academic recognition.

Conclusion

Methaq Hadi Lafta has established an interdisciplinary research profile spanning biotechnology, molecular medicine, bioinformatics, and biomedical sciences. The scholarly record includes peer-reviewed publications, editorial participation, and measurable research impact indicators. These academic contributions provide a basis for recognition within the Best Academic Researcher Award category associated with the Applied Scientist Awards.[2]

References

  1. Lafta, Methaq Hadi., Saif Adnan M. Advances in Engineering and Intelligence Systems (2022). Strategic Review: The CZTS Thin-Film Using Tandem and Multi-Junction Solar Cell.
    https://aeis.bilijipub.com/article_163968.html
  2. Hadi lafta, M., &  Markov, A. Cell Biology International (2021). P53 long noncoding RNA regulatory network in cancer development.
    https://onlinelibrary.wiley.com/doi/10.1002/cbin.11600
  3. Biomedicine & Pharmacotherapy. (2021). The developing role of extracellular vesicles in autoimmune diseases.
    https://www.sciencedirect.com/science/article/abs/pii/S1567576923008548
  4. Lafta, M.H., & Ahmadi, M. (2021). Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature.
    https://link.springer.com/article/10.1186/s12935-021-01836-9

Shuai Li | Biotechnology | Innovative Research Award

Innovative Research Award

Shuai Li
Regeneron Pharmaceuticals, Inc., United States

Shuai Li
Affiliation Regeneron Pharmaceuticals, Inc.
Country United States
Scopus ID 60626088100
Documents 1
Citations 9
h-index 1
Subject Area Biotechnology
Event Applied Scientist Awards
ORCID 0000-0002-1537-3956

Shuai Li has developed a research portfolio spanning biopharmaceutical formulation development, gene therapy analytics, metabolic engineering, and synthetic biology, with research outputs published in peer-reviewed journals and presented at major scientific conferences.[1] The Innovative Research Award recognizes emerging scientific contributions demonstrating originality, interdisciplinary relevance, and measurable research impact within applied scientific and pharmaceutical innovation. His work at REGENERON and prior academic institutions has focused on analytical characterization of adeno-associated virus (AAV) systems, bioprocess optimization, and translational pharmaceutical technologies.[2]

Abstract

Shuai Li is a researcher working in pharmaceutical sciences, biotechnology, and chemical engineering with emphasis on biologics formulation, gene therapy product characterization, and metabolic engineering. His research integrates analytical chemistry, bioprocess optimization, and automation-driven pharmaceutical development methodologies. Current work at Regeneron Pharmaceuticals, Inc. focuses on accelerated stability optimization platforms, adeno-associated virus formulation technologies, and analytical workflows supporting translational biopharmaceutical development.[2] Previous academic contributions include metabolic pathway engineering in engineered Escherichia coli, dynamic metabolic control systems, and supramolecular chemistry investigations.[3]

Keywords

Biopharmaceutical formulation, AAV stability, gene therapy, metabolic engineering, synthetic biology, analytical chemistry, pharmaceutical sciences, biotechnology, automation platforms, protein engineering.

Introduction

The development of advanced therapeutic biologics and gene therapy systems has accelerated the need for robust analytical technologies, scalable manufacturing workflows, and stability-driven formulation design. Contemporary pharmaceutical research increasingly requires interdisciplinary expertise spanning biotechnology, analytical chemistry, and process engineering.[4] Within this scientific context, Shuai Li has contributed to research involving AAV analytical characterization, formulation optimization, and engineered microbial biosynthesis systems aimed at improving pharmaceutical process efficiency and therapeutic development strategies.[5]

His research activities include high-throughput formulation screening, automated analytical platforms, process transfer methodologies, and characterization techniques supporting preclinical and clinical biologic development. The integration of engineering principles with pharmaceutical sciences has positioned his work within broader efforts to improve stability, manufacturability, and translational feasibility in therapeutic product development.[2]

Research Profile

Shuai Li currently serves as Principal Scientist at Regeneron Pharmaceuticals, Inc. in the United States, where his work centers on drug substance and drug product formulation development for biologics and novel therapeutic modalities, including AAV-based systems and antibody therapeutics.[2] His responsibilities include formulation stability studies, analytical method implementation, developability assessment, and technology transfer to manufacturing environments.

Prior academic research at Duke University focused on dynamic metabolic control systems, engineered microbial biosynthesis, and protein engineering methodologies for chemical production pathways. Earlier work at the Institute of Chemistry, Chinese Academy of Sciences, explored supramolecular chirality, chiral self-assembly, and molecular recognition systems.[3]

  • Principal Scientist, REGENERON Pharmaceuticals
  • Ph.D. in Chemical and Biological Engineering from Duke University
  • Research experience in pharmaceutical sciences and synthetic biology
  • Conference session chair at ASGCT scientific meetings
  • Contributor to analytical and formulation technologies for AAV therapeutics

Research Contributions

Shuai Li has contributed to the development of automated high-throughput systems for accelerated AAV stability optimization and analytical workflows supporting therapeutic characterization.[5] His work includes optimization of SEC methods for characterization of genome DNA leakage in adeno-associated virus products and analytical assessment of degradation pathways under stress conditions.[6]

In metabolic engineering research, he investigated dynamic control mechanisms to improve NADPH fluxes and xylitol biosynthesis in engineered microbial systems. These studies contributed to scalable and process-robust production approaches in engineered E. coli systems.[3]

Additional contributions include development of co-formulation methods, automation-assisted analytical workflows, and biochemical characterization methodologies relevant to pharmaceutical manufacturing and translational biotechnology.[2]

Publications

  • Li, S.; Wang, X.; Zhi, L.; Shameem, M.; Liu, D. “A high-throughput automation platform for accelerated AAV stability optimization.” Pharmaceutics, 2026.
  • Li, S.; Wang, X.; et al. “Development of an optimized SEC method for characterization of genome DNA leakage from adeno-associated virus products.” Analytical and Bioanalytical Chemistry, 2024.
  • Li, S.; Ye, Z.; Moreb, E. A.; et al. “2-Stage microfermentations.” Metabolic Engineering Communications, 2024.
  • Sun, Y.; Li, S.; et al. “Alanine-Based Chiral Metallogels via Supramolecular Coordination Complex Platforms.” Journal of the American Chemical Society, 2018.

Research Impact

Shuai Li reflect interdisciplinary integration between pharmaceutical development, analytical chemistry, and metabolic engineering. His scientific contributions have supported analytical characterization strategies for gene therapy systems, including AAV stability and degradation profiling.[5] The combination of automation-driven formulation platforms and scalable bioprocess methodologies demonstrates relevance to modern translational pharmaceutical research environments.

Bibliometric indicators associated with the profile include citations, peer-reviewed publications, conference presentations, and patent filings connected to therapeutic formulation and engineered biosynthesis technologies.[1] Participation as session chair and reviewer within scientific conferences further reflects engagement with the broader biotechnology and pharmaceutical research community.[2]

Award Suitability

Shuai Li demonstrates suitability for recognition within the Innovative Research Award category through contributions spanning biopharmaceutical formulation science, AAV characterization technologies, metabolic engineering, and analytical platform development.[4] His work combines translational applicability with interdisciplinary scientific methodologies relevant to pharmaceutical development and biotechnology innovation.

The profile further reflects active participation in scientific dissemination through peer-reviewed publications, conference leadership activities, patent filings, and collaborative research contributions. The integration of automation, analytical science, and therapeutic product development supports the broader objectives associated with applied scientific innovation awards.[2]

Conclusion

Shuai Li has established a multidisciplinary research profile integrating pharmaceutical sciences, analytical chemistry, biotechnology, and metabolic engineering. His work contributes to the development of advanced analytical methods, formulation technologies, and scalable therapeutic development systems relevant to contemporary biologics and gene therapy research. Through academic publications, patents, scientific leadership activities, and translational research efforts, the profile demonstrates alignment with the objectives of the Innovative Research Award and the Applied Scientist Awards program.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Shuai Li, Author ID 60626088100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60626088100
  2. Li, S. (2026). Professional Curriculum Vitae and Research Profile. REGENERON Pharmaceuticals.
    https://scholar.google.com/citations?user=gGjwsxkAAAAJ&hl=en
  3. Li, S.; Ye, Z.; Moreb, E. A.; et al. (2021). Dynamic control over feedback regulatory mechanisms improves NADPH fluxes and xylitol biosynthesis in engineered E. coli. Metabolic Engineering, 64, 26-40.
    https://doi.org/10.1016/j.ymben.2020.12.002
  4. Li Zhang, Han-Xiao Wang, Shuai Li, Minghua Liu. Supramolecular chiroptical switches.
    https://pubs.rsc.org/en/content/articlehtml/2020/cs/d0cs00191k
  5. Li, S,. et al. HardwareX (2021). BioSamplr: An open source, low cost automated sampling system for bioreactors. Pharmaceutics, 18(5), 608.
    https://www.sciencedirect.com/science/article/pii/S2468067221000067
  6. Chen, Y.; Li, S.; Li, S.; et al. (2023). Lyophilization as an effective tool to develop AAV8 gene therapy products for refrigerated storage
    https://www.sciencedirect.com/science/article/pii/S0378517323009857

Nisha Amarnath Jonniya | Biotechnology Awards | Women Researcher Award

Dr. Nisha Amarnath Jonniya | Biotechnology Awards | Women Researcher Award

Assistant Professor at National Institute of Technology Andhra Pradesh, India

Dr. Nisha Amarnath Jonniya is a dynamic and accomplished academician and researcher, currently serving as an Assistant Professor in the Department of Biotechnology at NIT Andhra Pradesh. With a profound expertise in computational biophysics and drug discovery, she has built a commendable research career focused on unraveling the conformational dynamics of biomolecules, particularly protein kinases implicated in various diseases. Dr. Jonniya obtained her Ph.D. from IIT Indore, where she investigated molecular modeling and simulation approaches for discovering inhibitors against hypertension-related kinases. Her professional journey spans prestigious institutions, including a current postdoctoral tenure at the University of California, San Diego under NIH funding. Her collaborative projects have addressed critical topics such as dengue virus inhibition and protein kinase regulation in Cushing’s syndrome. With over 30 high-impact publications and significant mentoring experience, Dr. Jonniya continues to contribute meaningfully to the fields of structural biology and computational drug design. Her dedication to translational research, coupled with active involvement in academic development programs and scientific outreach, underscores her commitment to both science and education.

Professional Profile

Education

Dr. Nisha Amarnath Jonniya’s academic journey exemplifies excellence and dedication. She completed her Ph.D. in Computational Biophysics from the Indian Institute of Technology (IIT) Indore, with a stellar CPI of 8.88. Her research, conducted under the guidance of Dr. Parimal Kar, focused on the conformational dynamics of kinases implicated in hypertension and involved molecular modeling and simulations to identify potent inhibitors. Prior to her doctoral studies, she earned an M.Tech in Bioinformatics from Maulana Azad National Institute of Technology (MANIT) Bhopal. Her M.Tech dissertation revolved around the application of support vector machine models for genotype classification in Hepatitis C Virus. Dr. Jonniya laid the foundation of her academic career with a B.Tech in Biotechnology from NIT Raipur, where she graduated with honors and departmental rank I. Her strong academic performance throughout her educational tenure, including top ranks at Kendriya Vidyalaya Kusmunda, reflects her consistent commitment to academic excellence and sets the groundwork for her future in high-impact research and teaching.

Professional Experience

Dr. Nisha Amarnath Jonniya’s professional experience spans prestigious institutions across India and the United States. Currently, she is serving as a Postdoctoral Employee at the University of California, San Diego (UCSD), where she is funded by the NIH to explore how disease-associated mutations affect the structure and function of Protein Kinase A. Under the mentorship of Prof. Susan Taylor, she is applying advanced computational techniques to elucidate allosteric regulations in kinases. Prior to this, Dr. Jonniya worked as a Research Associate at IIT Indore, focusing on antibody redesign and inhibitor identification against the dengue virus using in silico methods under a DST-funded project. She also served as a Lecturer at NIT Raipur from 2010 to 2015, where she taught undergraduate courses in biotechnology. Additionally, she held a teaching assistantship at IIT Indore during her Ph.D. studies. Her professional journey reflects a seamless integration of teaching, mentoring, and advanced research. Across these roles, she has contributed significantly to interdisciplinary biomedical research, mentored budding scientists, and fostered an academic environment conducive to collaborative innovation and scientific inquiry.

Research Interest

Dr. Nisha Amarnath Jonniya’s research interests lie at the intersection of structural biology, computational biophysics, and molecular drug design. Her work focuses on understanding the structural and thermodynamic properties of biomolecular systems, particularly proteins and glycans. She explores conformational dynamics using enhanced sampling molecular dynamics methods, providing insight into protein flexibility and function. A key emphasis of her research is on computational modeling of biomolecular recognition processes, including protein-protein and protein-ligand interactions, which are crucial for elucidating disease mechanisms and identifying therapeutic targets. Her projects have addressed critical biological problems, such as kinase regulation in hypertension and structural alterations in dengue virus proteins. Through structure-based drug discovery approaches, she has contributed to the identification of novel inhibitors and antibody enhancements. Dr. Jonniya’s ability to bridge theoretical modeling with translational biomedical applications underscores her long-term goal to contribute to precision medicine. Her research remains driven by the motivation to harness computational power for decoding complex biological phenomena and translating them into clinically relevant solutions.

Research Skills

Dr. Jonniya possesses a robust and versatile skill set in computational and bioinformatics tools essential for modern biomedical research. She is proficient in programming languages like Python, R, and shell scripting, and has advanced experience with molecular dynamics software such as AMBER and GROMACS. She routinely employs simulation and modeling tools like Schrodinger-Suite, Autodock, AlphaFold, UCSF Chimera, and PyMOL for structure-based drug design and protein analysis. Her skill set also includes visualization tools (VMD), plotting libraries (Matplotlib, Gnuplot), and LaTeX for scientific documentation. She has expertise in techniques such as sequence alignment, molecular docking, phylogenetic analysis, network analysis, virtual screening, and homology modeling. Dr. Jonniya is well-versed in both Windows and Linux operating systems, enhancing her adaptability across computational environments. Her command over enhanced sampling techniques, free energy calculations, and allosteric network mapping uniquely positions her for high-resolution insights into protein dynamics. These technical competencies, combined with a deep understanding of biomolecular interactions, empower her to lead impactful projects in structural biology and rational drug discovery.

Awards and Honors

Throughout her academic and professional career, Dr. Nisha Amarnath Jonniya has earned several notable accolades. She secured first rank in both her undergraduate (B.Tech in Biotechnology) and postgraduate (M.Tech in Bioinformatics) programs at NIT Raipur and MANIT Bhopal respectively, reflecting her exceptional academic abilities. She qualified the prestigious Graduate Aptitude Test in Engineering (GATE) in 2007 and was a consistent top performer from school through higher education. Dr. Jonniya received the Best Oral Presentation award at IIT Indore’s Symposium on Advances in Biosciences and Bioengineering in 2019. She has delivered invited talks and presented her research at renowned national and international platforms, including the Gordan Research Conference (USA) and Max Planck Institute (Germany). Her scientific contributions have been published in prestigious journals such as PNAS, eLife, and the Journal of Physical Chemistry B. In recognition of her expertise, she has served as a reviewer for reputed journals including ACS Omega and the Journal of Biomolecular Structure and Dynamics. These honors underscore her academic excellence, leadership in research, and ongoing contributions to the scientific community.

Conclusion

Dr. Nisha Amarnath Jonniya represents the epitome of dedication, innovation, and academic brilliance in the field of computational biology. Her multidisciplinary background, encompassing biotechnology, bioinformatics, and biophysics, has enabled her to address pressing biomedical challenges through in silico approaches. From top academic ranks to international collaborations and high-impact publications, her journey reflects a commitment to excellence and a passion for scientific inquiry. As an educator, she has not only taught and mentored students at premier institutions but also organized and participated in numerous scientific workshops and conferences, contributing to knowledge dissemination and capacity building. Her research continues to break new ground in understanding molecular mechanisms of diseases and designing targeted therapeutics. Moving forward, Dr. Jonniya is well-positioned to make transformative contributions to personalized medicine, drug development, and molecular therapeutics. Her career serves as a model for aspiring researchers aiming to blend computational skills with biological insight to tackle complex healthcare problems of the 21st century.

Publications Top Notes

  • Title: Current and novel therapeutic molecules and targets in Alzheimer’s disease
    Authors: A. Kumar, C.M. Nisha, C. Silakari, I. Sharma, K. Anusha, N. Gupta, P. Nair, …
    Year: 2016
    Citations: 191

  • Title: Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β‐Secretase
    Authors: C.M. Nisha, A. Kumar, P. Nair, N. Gupta, C. Silakari, T. Tripathi, A. Kumar
    Year: 2016
    Citations: 166

  • Title: Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor
    Authors: C.M. Nisha, A. Kumar, A. Vimal, B.M. Bai, D. Pal, A. Kumar
    Year: 2016
    Citations: 119

  • Title: Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations
    Authors: M.F. Sk, R. Roy, N.A. Jonniya, S. Poddar, P. Kar
    Year: 2021
    Citations: 86

  • Title: Investigating phosphorylation-induced conformational changes in WNK1 kinase by molecular dynamics simulations
    Authors: N.A. Jonniya, M.F. Sk, P. Kar
    Year: 2019
    Citations: 51

  • Title: Computational investigation of structural dynamics of SARS-CoV-2 methyltransferase-stimulatory factor heterodimer nsp16/nsp10 bound to the cofactor SAM
    Authors: M.F. Sk, N.A. Jonniya, R. Roy, S. Poddar, P. Kar
    Year: 2020
    Citations: 44

  • Title: Identification of potential inhibitors against Epstein–Barr virus nuclear antigen 1 (EBNA1): An insight from docking and molecular dynamic simulations
    Authors: S. Jakhmola, N.A. Jonniya, M.F. Sk, A. Rani, P. Kar, H.C. Jha
    Year: 2021
    Citations: 40

  • Title: Immunoinformatics approach to design multi-epitope-subunit vaccine against bovine ephemeral fever disease
    Authors: S. Pyasi, V. Sharma, K. Dipti, N.A. Jonniya, D. Nayak
    Year: 2021
    Citations: 35*

  • Title: Investigating specificity of the anti-hypertensive inhibitor WNK463 against With-No-Lysine kinase family isoforms via multiscale simulations
    Authors: N.A. Jonniya, P. Kar
    Year: 2020
    Citations: 30

  • Title: Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies
    Authors: R. Roy, M.F. Sk, N.A. Jonniya, S. Poddar, P. Kar
    Year: 2022
    Citations: 23

Tingting Li | Biotechnology | Best Researcher Award

Dr. Tingting Li | Biotechnology | Best Researcher Award

Lecturer From Jiangsu Ocean University, China

Dr. Tingting Li is a highly accomplished academic, currently serving as a Lecturer and Master’s Supervisor at the School of Pharmaceutical Sciences, Jiangsu Ocean University. With a multidisciplinary background in biotechnology, biochemistry, molecular biology, and developmental biology, she integrates advanced knowledge and research to address significant scientific challenges. Her expertise centers on enzyme structural biology, synthetic biology, and mechanisms of plant stress tolerance. Dr. Li is known for her contributions to both teaching and research, guiding numerous graduate students and instructing undergraduate and postgraduate courses such as Enzyme Engineering and Biochemistry. Her scholarly output includes 15 peer-reviewed publications and two patents, reflecting her commitment to innovation and real-world application. She has led multiple research projects as the principal investigator, funded by the Jiangsu Provincial Natural Science Foundation and collaborative industry-academia initiatives. Dr. Li is also actively involved in structural and functional analysis of enzymes and membrane proteins, bringing deep insights into protein engineering and molecular dynamics. A dynamic mentor, educator, and researcher, Dr. Li exemplifies academic excellence, intellectual curiosity, and scientific leadership. Her work not only contributes to the field of pharmaceutical sciences but also promotes sustainable solutions and novel therapeutic strategies through interdisciplinary collaboration.

Professional Profiles

Education

Dr. Tingting Li’s academic journey has been marked by rigorous training and interdisciplinary focus, laying the groundwork for her research in pharmaceutical sciences. She earned her Ph.D. in Developmental Biology from Wuhan University in 2018, where she conducted significant research on molecular mechanisms regulating plant responses to environmental stress. During her doctoral studies, she developed a strong foundation in molecular biology, cellular signaling pathways, and biochemical techniques. Prior to that, she obtained her M.S. in Biochemistry and Molecular Biology from Jilin Agricultural University in 2012. Her master’s thesis focused on enzyme activity and functional genomics, which introduced her to structural biology and bioinformatics. Dr. Li began her academic career with a B.S. in Biotechnology from Shandong Agricultural University in 2009, where she first developed her passion for molecular science and laboratory research. These degrees have equipped her with a diverse and in-depth understanding of biological systems, from basic biotechnological principles to complex regulatory networks in living organisms. Each stage of her education contributed to her development as a researcher, fostering her analytical thinking, problem-solving skills, and technical proficiency. Her solid academic background now underpins her success as an educator, investigator, and mentor in the evolving field of marine pharmaceutical science.

Professional Experience

Dr. Tingting Li brings over a decade of professional experience in academic research and education. Since July 2018, she has served as a Lecturer and Master’s Supervisor at Jiangsu Ocean University’s School of Pharmaceutical Sciences, contributing to the Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening. In this role, she leads research projects focusing on enzyme structural biology, synthetic biology, and plant stress tolerance mechanisms. Her work bridges basic research with applied pharmaceutical solutions, using innovative approaches to enzyme engineering and molecular design. She mentors more than five graduate students, providing scientific guidance and helping them navigate their academic careers. She also teaches core courses such as Enzyme Engineering and Biochemistry, integrating hands-on learning and cutting-edge research into the curriculum. Prior to this, Dr. Li worked as a Research Associate at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2012–2014), where she specialized in structural and functional studies of membrane proteins. There, she gained extensive experience in protein crystallization and structure-function analysis, which remains central to her current research. Her blend of research and teaching experience has made her a respected figure in the pharmaceutical sciences community, known for her collaborative spirit, academic integrity, and scientific acumen.

Research Interest

Dr. Tingting Li’s research interests lie at the intersection of structural biology, enzyme engineering, synthetic biology, and plant stress physiology. A major focus of her work is elucidating the structure-function relationship of enzymes to develop novel biocatalysts with industrial and pharmaceutical applications. She is particularly interested in characterizing thermostable and solvent-tolerant transaminases and exploring their use in asymmetric synthesis and green chemistry. Her studies often employ X-ray crystallography and molecular dynamics simulations to understand protein behavior at the atomic level, enabling rational design and directed evolution of enzymes. Another area of her research investigates plant stress tolerance mechanisms, especially how molecular signaling pathways are modulated under abiotic stress conditions like salinity and drought. Her previous work on sorting nexins and nitric oxide signaling in plants has revealed potential targets for improving crop resilience. Furthermore, Dr. Li’s collaborative projects with industry explore the scalability of enzymatic processes and sustainable bioproduction. She aims to bridge basic biological insights with applied innovation, contributing to advancements in pharmaceutical development, agriculture, and environmental biotechnology. Through interdisciplinary research and strong academic collaboration, Dr. Li aspires to solve real-world problems by leveraging the power of biomolecular science.

Research Skills

Dr. Tingting Li possesses a comprehensive and technically diverse skill set, essential for high-level research in pharmaceutical and biological sciences. In the field of structural biology, she is proficient in X-ray crystallography, protein purification, and crystallization techniques. Her experience includes solving crystal structures of complex proteins such as odorant binding proteins and membrane proteins, contributing to a deeper understanding of molecular function and interaction. She is also skilled in computational modeling and molecular dynamics simulations, which she uses to investigate enzyme stability and design mutations for improved activity or selectivity. In enzyme engineering, Dr. Li employs strategies such as directed evolution, site-directed mutagenesis, and metabolic pathway reconstruction. She designs biocatalysts for industrial applications, including the asymmetric synthesis of amines and other pharmaceutical intermediates. Her lab expertise spans from molecular cloning and gene expression to high-throughput screening of enzyme variants. Additionally, she is adept at integrating multi-disciplinary tools for systems biology, including plant molecular biology methods to analyze stress-response pathways. Dr. Li’s technical skills are complemented by her analytical thinking and problem-solving approach, enabling her to manage complex experiments and collaborative projects. Her hands-on experience across multiple scientific domains positions her as a leader in both fundamental and translational research.

Awards and Honors

Throughout her academic and professional journey, Dr. Tingting Li has been recognized for her contributions to scientific research and academic excellence. She has successfully secured funding as the Principal Investigator for multiple competitive grants, including two projects from the Jiangsu Provincial Natural Science Foundation General Program since 2022. These grants support her innovative research on enzyme function, structure-based drug design, and plant tolerance mechanisms. Additionally, Dr. Li has led three major industry-academia collaborative projects since 2023, demonstrating her ability to translate basic research into practical applications with real-world impact. Her research findings have been published in internationally renowned journals such as ChemBioChem, Chemical Biodiversity, and Frontiers in Plant Science, earning her recognition within the global scientific community. Beyond publications, Dr. Li holds two patents related to enzyme discovery and co-extraction methods, showcasing her commitment to innovation and intellectual property development. Her mentorship of graduate students and contribution to teaching have also garnered praise within Jiangsu Ocean University, highlighting her balanced commitment to education and research. These accolades reflect Dr. Li’s sustained excellence, scientific rigor, and leadership in a competitive and evolving research environment.

Conclusion

Dr. Tingting Li stands out as a dynamic and impactful figure in the field of pharmaceutical sciences, blending deep scientific expertise with a strong commitment to education and innovation. Her multidisciplinary background and research interests have led to significant advances in enzyme engineering, structural biology, and plant stress physiology. Through both her academic roles and research leadership, she contributes meaningfully to the development of sustainable and innovative solutions in biotechnology and pharmaceuticals. Dr. Li’s ability to secure competitive research funding and produce high-quality publications and patents underscores her commitment to scientific advancement. Equally dedicated to student mentorship, she fosters a collaborative learning environment that prepares young researchers for success in academia and industry alike. Her professional journey reflects a balance of discovery, application, and mentorship—an embodiment of the modern scientific scholar. Looking ahead, Dr. Li aims to expand her research through interdisciplinary collaboration, industrial partnerships, and global engagement. Her long-term vision is to develop novel bio-based solutions that address critical challenges in health, agriculture, and the environment. With a career marked by innovation, integrity, and academic excellence, Dr. Li continues to be a driving force in shaping the future of marine pharmaceutical science.

 Publications Top Notes

  • Title: Identification, characterization and application of M16AT, a new organic solvent–tolerant (R)–enantio–selective type IV amine transaminase from Mycobacterium sp. ACS1612

  • Authors: Tingting Li, Hai Zhu, Weiwei Jia, Xia Tian, Ziwen Xu, Jiang Zhu, Wencheng Liu, Yang Cao

  • Year: 2024